• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

PCORI Board approves $2.3 million to support implementation of results from PCORI-funded research

Bioengineer by Bioengineer
July 23, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Projects focus on lung cancer screening and therapy for adolescent traumatic brain injury

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $2.3 million to fund two projects designed to advance the spread and use of PCORI-funded research findings in real-world practice. Both awards were made through PCORI’s Dissemination and Implementation initiative.

The first award is for a $1.4 million University of Texas MD Anderson Cancer Center project seeking to expand use of a decision aid shown in PCORI-funded research to help patients at high risk for lung cancer make better-informed decisions about being screened for the disease.  The project will train staff at smoking “quitlines” in eight states to identify and refer high-risk smokers to use the decision aid–“Lung Cancer Screening: Is It Right for Me?”–and other resources that can encourage and prepare them to discuss screening with a healthcare provider. The goal is to help increase lung cancer screening rates, which are low nationwide.

The second award is for an $860,000 Cincinnati Children’s Hospital project designed to improve care for adolescents with behavior problems following traumatic brain injury (TBI). The project seeks to increase access to a special type of TBI therapy called family problem-solving therapy (F-PST). Previous PCORI-funded research showed that receiving a less resource-intensive form of F-PST through a self-guided online program was as effective as therapist-guided online F-PST and in-person therapy in a clinic.

The newly approved project will implement all three approaches at 10 children’s hospitals and rehabilitation centers in seven states. The hope is that the self-guided online option will expand families’ access to needed post-TBI care; more than half of adolescents with behavior problems following TBI don’t receive treatment and few therapists are trained in F-PST for TBI.

“PCORI’s mission is not just to fund research that will help patients and clinicians make better-informed choices about their healthcare options, but to actively promote the dissemination and implementation of the results of those studies,” said PCORI Executive Director Joe Selby, MD, MPH. “These latest awards will help to do that, supporting efforts to see that useful evidence is more quickly available in the real world.”

“Even the strongest evidence can’t improve patient care and outcomes if not taken up in routine practice,” added Jean R. Slutsky, PA, MSPH, PCORI’s chief engagement and dissemination officer. “As we continue to see more promising results from PCORI-funded studies, we are building on our dissemination and implementation work to ensure this evidence gets to healthcare decision makers in ways they can most easily and effectively use it.”

With these latest awards, PCORI has approved nearly $31 million in projects designed to support the uptake of selected results from PCORI-funded research to help patients and those who care for them make better-informed healthcare decisions. More details on all of PCORI’s dissemination and implementation projects are on PCORI’s website.

The Board also heard an overview of PCORI’s portfolio of research to improve care for people with multiple sclerosis (MS), which affects as many as 1 million Americans, according to the National Multiple Sclerosis Society. PCORI has awarded $69 million to support 12 studies and related projects seeking to determine which care approaches work best in treating MS symptoms. These studies span the range from comparing medications and other therapies used to slow the progression of MS, to assessing therapies designed to treat symptoms, and comparing the effectiveness of rehabilitation delivered through telehealth to conventional direct care. More information on those projects is available on PCORI’s website.

###

About PCORI

The Patient-Centered Outcomes Research Institute (PCORI) is an independent nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information they need to make better-informed healthcare decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work.

Media Contact
Mary McNamara
[email protected]
https://www.pcori.org/news-release/pcori-board-approves-2-2-million-support-implementation-results-pcori-funded-research

Tags: cancerCarcinogensClinical TrialsCritical Care/Emergency MedicineHealth CareMedicine/HealthSmoking/Tobacco
Share12Tweet8Share2ShareShareShare2

Related Posts

Ongoing Use of Nasogastric Tubes Following Esophageal Cancer Surgery Receives Backing

Ongoing Use of Nasogastric Tubes Following Esophageal Cancer Surgery Receives Backing

July 31, 2025
RIPK1 S213E Mutation Blocks Cell Death Interactions

RIPK1 S213E Mutation Blocks Cell Death Interactions

July 31, 2025

Biomarker Panels Boost Atrial Fibrillation Risk Insights

July 31, 2025

Brain Imaging Could Predict Which Patients Will Benefit Most from Anxiety Care Apps

July 31, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Proteogenomic Study of Healthy vs. Cancerous Prostate Tissues Leveraging SILAC and Mutation Databases

Here’s a rewritten version of the headline for a science magazine post: “Could Desert Dust Hold the Key to Freezing Clouds?”

Lightning strikes kill 320 million trees annually, causing significant biomass loss

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.